Assessment of quality and clinical effectiveness of apheresis platelet concentrates treated with mirasol pathogen reduction system in plasma or in platelet additive solution SSP

被引：0
|
作者：
Ignatova, A. [1 ]
Karpova, O. [1 ]
Trahtman, P. [1 ]
Rumyantsev, S. [1 ]
Panteleev, M. [1 ]
机构：
[1] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO569-MON
引用
收藏
页码：467 / 468
页数：2
相关论文
共 50 条
  • [21] Storage of platelet concentrates in plasma or in a platelet additive solution.
    van der Meer, PF
    Rebers, SPH
    Pietersz, RNI
    Hinloopen, B
    Dekker, WJA
    Reesink, HW
    [J]. TRANSFUSION, 1998, 38 (10) : 18S - 18S
  • [22] Platelet concentrates and fresh frozen plasma from whole blood treated with the Mirasol® system
    Reddy, H.
    Doane, S.
    Fitzpatrick, C.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 231A - 231A
  • [23] A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology
    Salunkhe, Vishal
    De Cuyper, Iris M.
    Papadopoulos, Petros
    van der Meer, Pieter F.
    Daal, Brunette B.
    Villa-Fajardo, Maria
    de Korte, Dirk
    van den Berg, Timo K.
    Gutierrez, Laura
    [J]. PLATELETS, 2019, 30 (03) : 368 - 379
  • [24] A COMPREHENSIVE PROTEOMICS STUDY ON PLATELET CONCENTRATES: PLATELET PROTEOME, STORAGE TIME AND MIRASOL PATHOGEN REDUCTION TECHNOLOGY
    Salunkhe, V.
    van Alphen, F.
    De Cuyper, I. M.
    Nota, B.
    van der Zwaan, C.
    van der Meer, P. F.
    Daal, B. B.
    De Korte, D.
    Meijer, A. B.
    van den Berg, T. K.
    Gutierrez, L.
    [J]. HAEMATOLOGICA, 2017, 102 : 141 - 141
  • [25] Evaluation of the quality of Apheresis platelets treated with Mirasol® pathogen reduction technology
    Eakins, E.
    Murphy, C.
    Croxon, H.
    Birhire, R.
    Flynn, N.
    Taylor, S.
    Murphy, W.
    [J]. TRANSFUSION, 2008, 48 (02) : 21A - 21A
  • [26] Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction
    Tauszig, Marie E.
    Picker, Susanne M.
    Gathof, Birgit S.
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2012, 46 (01) : 33 - 37
  • [27] Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates
    Marini, Irene
    Aurich, Konstanze
    Jouni, Rabie
    Nowak-Harnau, Stefanie
    Hartwich, Oliver
    Greinacher, Andreas
    Thiele, Thomas
    Bakchoul, Tamam
    [J]. HAEMATOLOGICA, 2019, 104 (01) : 207 - 214
  • [28] In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days
    Braathen, Hanne
    Sivertsen, Joar
    Lunde, Turid Helen Felli
    Kristoffersen, Einar Klaeboe
    Assmus, Jorg
    Hervig, Tor Audun
    Strandenes, Geir
    Apelseth, Torunn Oveland
    [J]. TRANSFUSION, 2019, 59 (08) : 2652 - 2661
  • [29] Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products
    Li, J
    de Korte, D
    Woolum, MD
    Ruane, PH
    Keil, SD
    Lockerbie, O
    McLean, R
    Goodrich, RP
    [J]. VOX SANGUINIS, 2004, 87 (02) : 82 - 90
  • [30] The effects of pathogen reduction technology on apheresis platelet concentrates stored in Pas
    Tsalas, Stavros
    Tsantes, Andreas G.
    Petrou, Eleni
    Mellou, Sofia
    Sokou, Rozeta
    Loukopoulou, Electra
    Kriebardis, Anastasios G. .
    Fortis, Sotirios P.
    Papadopoulos, Dimitrios V.
    Vaiopoulos, Aristeidis G.
    Kokoris, Styliani
    Tsantes, Argirios E.
    [J]. BLOOD TRANSFUSION, 2024, 22 (05)
12345